Consensus Radiopharm Theranostics Limited

Equities

RAD

AU0000181851

Market Closed - Australian S.E. Other stock markets 02:10:05 2024-04-29 am EDT			5-day change	1st Jan Change
0.045 ^AUD	-2.17%		+2.27%	-39.19%

Feb. 29	Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study	MT
Feb. 29	Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Evolution of the average Target Price on Radiopharm Theranostics Limited

Price target over the last 5 years

History of analyst recommendation changes

bd60025cb109e59db0b177d.NimMyrVJ-siB2sGvvYUfnYGj-u8LVZ_QmYqlJQzZLTU.f0fZodIQi6m3hZbo-sJ7zbjEot0yAsqf_d_1fVuvRUEHbMGvxBDDkdvttg~7be956c5c0bfb26de838b69d704452f4

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.0295 USD

Average target price

0.317 USD

Spread / Average Target

+973.93%

High Price Target

0.462 USD

Spread / Highest target

+1,465.15%

Low Price Target

0.172 USD

Spread / Lowest Target

+482.70%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar